Clinical Trial Update: Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating metformin for target validation and potential efficacy in patients with posterior fossa ependymoma (PFA group A). The stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posterior Fossa Ependymoma

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: University of California, San Francisco | Conditions: Posterior Fossa Ependymal Tumor | Phase 2 | Status: NOT_YET_RECRUITING